Geode Capital Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-46,800
Closed -$4.97M 3955
2014
Q2
$4.97M Sell
46,800
-5,586
-11% -$548K ﹤0.01% 1796
2014
Q1
$4.56M Buy
52,386
+7,269
+16% +$561K ﹤0.01% 1836
2013
Q4
$1.9M Buy
45,117
+471
+1% +$19.4K ﹤0.01% 2322
2013
Q3
$1.96M Buy
44,646
+856
+2% +$35.4K ﹤0.01% 2182
2013
Q2
$1.49M Buy
+43,790
New +$1.54M ﹤0.01% 2219

Geode Capital Management's FURX Position: Q3 2014 in Review

Geode Capital Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 46,800 shares — an estimated $4.97M sold.

Geode Capital Management first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $4.97M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Geode Capital Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Geode Capital Management sold 46,800 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $4.97M.
  • Geode Capital Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Geode Capital Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $4.97M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Geode Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.